Evidence map›Paper›PMID 41539560›Full record

ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2026

Value-Based Pricing of Health Services With Health Equity Considerations.

Luigi Siciliani, Simon Walker, David Glynn, Ni Gao, Nils Gutacker, Tim Doran

Abstract read
In one paragraph

Article in Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luigi SicilianiDepartment of Economics and Related Studies, University of York, York, England, UK. Electronic address: luigi.siciliani@york.ac.uk.
Simon WalkerCenter for Health Economics, University of York, York, England, UK.
David GlynnCÚRAM Research Ireland Center for Medical Devices, Ireland; Health Economics and Policy Analysis Center, University of Galway, Galway, Ireland.
Ni GaoCenter for Health Economics, University of York, York, England, UK.
Nils GutackerCenter for Health Economics, University of York, York, England, UK.
Tim DoranDepartment of Health Sciences, University of York, York, England, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMany health systems aim to reduce health inequalities. Reimbursement mechanisms for healthcare providers, including pay-for-performance, are common policy levers to align provider behavior with health systems objectives. We develop a methodology to incorporate equity concerns into value-based pricing in the English National Health Service. We focus on socioeconomic inequalities in health measured by deprivation quintiles. We show how changes in the design of a national pay-for-performance scheme in primary care, the Quality Outcome Framework, can be evaluated in terms of their effects on the level and distribution of health across socioeconomic status.

methodsAfter developing our theoretical framework, which is based on Distributional Cost-Effectiveness Analysis and contract theory, we calibrate a model of physician behavior using information on costs and health benefits of different incentivized activities, achievement rates, and supply responsiveness to prices. We evaluate the effect of hypothetical 20% increases in price of 1 incentivized activity, which is financed by a reduction in another price to retain budget neutrality. Trade-offs between efficiency and socioeconomic inequalities in health are evaluated using the Equally Distributed Equivalent level of health.

resultsWe illustrate our methodology using 3 scenarios: changes in prices for 2 incentivized activities for the same health condition (diabetes), different health conditions (diabetes and chronic obstructive pulmonary disease), and across socioeconomic groups within the same activity (flu vaccination for diabetes patients).

conclusionsOur analysis illustrates how inequality aversion can be incorporated into value-based pricing when assessing the effect of financial incentives on the health distribution across socioeconomic groups.

Indexed as

Health EquityReimbursement, IncentiveState MedicineCost-Benefit AnalysisCost-Effectiveness AnalysisCosts and Cost AnalysisHealthcare DisparitiesHumansPrimary Health CareSocioeconomic Disparities in HealthValue-Based Health Carefinancial incentiveshealthhealthcareinequalitiespay for performancevalue-based pricing

Identifiers

PMID41539560
PMCPMC13259816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.